OpenNashPodcasts

Leadership Next (Fortune)

Janet Yellen on the Current State of the Economy and Joaquin Duato on why J & J is in its "Golden Era"

10 Oct 2023 · 32m · Alan Murray, Joaquin Duato, Janet Yellen, Jason Garzadas, Michal Lev-Ram · 24 quoted facts

▶ Play episodeOriginal source ↗

In brief

This episode argues that purpose-driven leadership helps organizations absorb shocks, and that the U.S. economy is in better shape than the headlines suggest. Johnson & Johnson CEO Joaquin Duato says clear principles and a narrower focus on healthcare prepare the company for a "golden era" of medical technology. Treasury Secretary Janet Yellen says a soft landing and manageable debt costs support her optimism.

The tension is between confidence and unresolved risk. Duato must lead through lawsuits and a withdrawn COVID-19 vaccine while betting on AI and robotics. Yellen is upbeat on inflation and productivity but admits she does not know how long interest rates will stay high. Host Alan Murray sums up the mood: leaders are caught between fear of missing out on AI and fear of getting in.

Key insights

  1. J&J spun off consumer brands to focus

    Duato says competing with L'Oreal in skincare while also competing in biologics and surgical robotics was too complex. Moving Band-Aid, Tylenol and baby shampoo into a separate company lets J&J concentrate on healthcare R&D.

  2. J&J's R&D scale underpins its optimism

    Duato says J&J invested $14.6 billion in R&D last year, possibly the most in life sciences. He expects AI, machine learning and smarter surgical instruments to speed drug discovery and improve surgical outcomes.

  3. Duato leans on the credo in crises

    He says J&J takes responsibility for mistakes but stands by its products when the facts, science and law support them. He calls the 80-year-old credo the source of that conviction and says purpose-driven companies manage change better.

  4. Yellen sees debt as sustainable for now

    She says the best measure is real net interest payments as a share of GDP, which she puts at about 1% over the next decade. She adds that this assumes meaningful deficit reduction and interest rates returning to more normal levels.

  5. Rising yields are Yellen's open question

    She admits she does not know how long rates will stay high. Ten-year nominal and real yields have risen noticeably in recent months, and she does not know whether that signals a lasting shift or a temporary one.

Questions

Why did Johnson & Johnson spin off its consumer business?

CEO Joaquin Duato said it was too complex to compete with L'Oreal in skincare while also competing in biologics and surgical robotics. Splitting off the consumer brands lets J&J focus on healthcare, research and innovation.

What does Johnson & Johnson mean by its credo, and why does it matter?

The credo is a statement written 80 years ago that puts patients first, then employees and communities, then shareholders. Duato says it guides J&J through crises like lawsuits and the withdrawn vaccine, and he argues purpose-driven companies handle change better.

What is a soft landing, and does Janet Yellen think it is happening?

A soft landing is when inflation falls without a recession or mass job losses. Yellen says inflation is coming down while the labor market stays very strong, and Alan Murray agrees it may actually happen.

Is the U.S. budget deficit a problem, according to Treasury Secretary Yellen?

Yellen says she must worry about fiscal sustainability but thinks the U.S. is on a sustainable path. Her yardstick is real net interest payments as a share of GDP, which she says is about 1% over the next decade.

Will generative AI quickly boost productivity?

Alan Murray cited researcher Erik Brynjolfsson as saying this wave of technology may show up in productivity data faster than the usual ten years. Yellen said she is not an AI expert and expects a payoff but did not want to exaggerate it.

Facts

Stated by the speakers. Each quote matches the transcript, which shows what was said, not that it is true.

The Fortune CEO Initiative was created to give CEOs of purpose-driven companies a forum to exchange ideas on improving their social impact.

“the Fortune CEO initiative was created seven years ago to give CEOs of purpose-driven companies that really want to focus on improving their positive social impact on society”

0:00:49 · Alan Murray · CEO Initiative · 2016

About 100 CEOs attended the 2023 Fortune CEO Initiative conference in Washington, D.C., according to Alan Murray.

“We had about 100 CEOs in the room and a killer program”

0:00:49 · Alan Murray · Conference attendance · 2023

Joaquin Duato became CEO of Johnson & Johnson in early 2022 after joining the company about 34 years earlier through Janssen Pharmaceuticals in Spain.

“Joaquin became CEO of J &J in early 2022, but he joined the company 34 years ago as part of Janssen Pharmaceuticals in his native Spain.”

0:02:36 · Michal Lev-Ram · Duato career · 2022

Johnson & Johnson faced a settlement of about $9 billion over a class action lawsuit alleging its baby powder caused cancer.

“we all know about this settlement, $9 billion class action lawsuit alleging that J &J's baby powder had caused cancer”

0:02:36 · Michal Lev-Ram · Talc litigation

Johnson & Johnson is one of 49 companies on every Fortune 500 list since 1955 and ranked number 40 in the 2023 list.

“Johnson & Johnson has been one of 49 companies to be in the Fortune 500 list every single year since we've made it since 1955. This year they clocked in at number 40.”

0:04:10 · Michal Lev-Ram · Fortune 500 · 2023

Joaquin Duato said Johnson & Johnson has had only eight CEOs in about 130 years and that he is the first born outside the United States.

“In our 130 years of history, we have had only eight CEOs. And I am the first one who is not born in the U.S.”

0:04:39 · Joaquin Duato · J&J leadership

Joaquin Duato was not advanced to a second interview when he first interviewed with Johnson & Johnson after graduate school, and he joined another pharmaceutical company before returning.

“when I finished graduate school, I interviewed with Johnson & Johnson, and I didn't make it to the second interview.”

0:05:33 · Joaquin Duato · Duato career

Joaquin Duato said average employee tenure at Johnson & Johnson in the U.S. is more than a decade.

“Our average tenure, for example, in the U.S. is more than a decade.”

0:06:41 · Joaquin Duato · Employee tenure

Johnson & Johnson spun out its consumer health business as Kenvue earlier in 2023, and Kenvue is now publicly traded.

“Kenview, which is the company that you spun out just earlier this year. It's now publicly traded.”

0:07:03 · Michal Lev-Ram · Kenvue spin-off · 2023

Joaquin Duato said Band-Aid, Tylenol and baby shampoo brands now sit within the separated consumer company Kenvue.

“Band-Aids, Tylenol, or baby shampoo, now they are all in Canview.”

0:07:34 · Joaquin Duato · Kenvue brands · 2023

Joaquin Duato said competing with L'Oreal in skincare while also competing in biologics and surgical robotics was too complex for Johnson & Johnson.

“For us, it was very complex to be able to compete with L 'Oreal, as you mentioned, in skincare and at the same time competing biologics with biopharmaceutical companies and in surgical robotics with medical technology companies.”

0:07:34 · Joaquin Duato · Spin-off rationale

Joaquin Duato said Johnson & Johnson can work in cell therapy, robotic surgery, genetic and mRNA therapeutics and smart implants.

“We can do cell therapy, but we can do robotic surgery. We can do genetic or mRNA therapeutics, and we can do also smart implants.”

0:11:26 · Joaquin Duato · J&J capabilities

Johnson & Johnson's credo, a statement of company principles, was written 80 years before 2023, according to Joaquin Duato.

“this year is the 80th anniversary of the credo that was written”

0:12:10 · Joaquin Duato · J&J credo · 2023

Alan Murray said Janet Yellen and her husband George Akerlof team taught his macroeconomics course at the London School of Economics.

“I got a master's degree in economics at the London School of Economics, and it happened to be the same year she had just gotten married and she and her new husband, George Akerlof, team taught my macroeconomics course.”

0:16:44 · Alan Murray · Murray and Yellen

The late-September 2023 funding deal only delayed a government shutdown by 45 days, and Moody's was threatening to downgrade U.S. debt, according to Alan Murray.

“all that happened was they kicked the ball down the road 45 days. And Moody's is threatening to downgrade U.S. debt.”

0:19:02 · Alan Murray · Government shutdown · 2023

Treasury Secretary Janet Yellen said in 2023 that inflation was falling while the labor market stayed very strong, which she described as a soft landing.

“inflation is coming down in the context of an extremely strong labor market, what people would normally call a soft landing.”

0:19:20 · Janet Yellen · Soft landing · 2023

Janet Yellen said the best measure of fiscal sustainability is real net interest payments as a share of GDP.

“the amount that we're spending to service the debt, real net interest payments as a share of GDP”

0:22:23 · Janet Yellen · Fiscal sustainability

Janet Yellen said the administration's Mid-Session Review projected real net interest at about 1% of GDP over the next decade, which she called historically normal.

“So real net interest as a share of GDP is about 1%. That's historically completely normal.”

0:23:03 · Janet Yellen · Federal debt · 2023

Janet Yellen said ten-year nominal and real Treasury yields had risen significantly over the preceding several months of 2023.

“we are seeing, especially over the last several months, a pretty significant increase in not only 10-year nominal yields, but also real yields.”

0:25:05 · Janet Yellen · Interest rates · 2023

Alan Murray said Erik Brynjolfsson told the conference that technology waves usually take about ten years to appear in productivity data, though he thinks generative AI may be faster.

“Eric Brynolfsson said earlier that most waves of technology take like 10 years before you start to see them in the productivity numbers.”

0:26:16 · Alan Murray · AI productivity · 2023

Janet Yellen cited the bipartisan infrastructure bill, the CHIPS and Science Act and the Inflation Reduction Act as legislation to boost productivity.

“we passed really a trifecta of legislation, the bipartisan infrastructure bill, the Chips and Semiconductor Act, and then the Inflation Reduction Act.”

0:27:47 · Janet Yellen · Industrial policy

Alan Murray said CEOs had predicted a recession about six months before October 2023, yet the U.S. economy had not entered one.

“it is pretty remarkable, given that every CEO we talked to six months ago was predicting a recession, that we are where we are, not in a recession.”

0:28:57 · Alan Murray · Recession outlook · 2023

Jennifer Tejada, CEO of PagerDuty, co-chaired the 2023 Fortune CEO Initiative conference and led a town hall on AI.

“Jennifer Tejada, who you know, who's the CEO of PagerDuty and was our co-chair for the conference, led a town hall discussion on the AI topic.”

0:30:28 · Alan Murray · AI town hall · 2023

Alan Murray relayed Jennifer Tejada's view that big-company CEOs felt caught between fear of missing out on AI and fear of getting in.

“most of the big company CEOs seem to be caught somewhere between FOMO, fear of missing out, and FOGI, fear of getting in.”

0:30:28 · Alan Murray · CEO attitudes to AI · 2023

Chapters

  1. 0:00:49Fortune CEO Initiative and the AI obsession

    Murray explains the conference's purpose and why generative AI dominated every session, setting up the two interviews.

    “give them a forum where they could exchange ideas and best practices”
  2. 0:07:34Why J&J spun out its consumer brands

    Duato explains the split of consumer products into a separate company so J&J can concentrate on healthcare.

    “focusing on the consumer market and focusing on healthcare was going to deliver better results”
  3. 0:09:04R&D, AI and smarter surgery

    Duato describes how large R&D spending, AI and connected surgical tools underpin his "golden era" view.

    “we invested $14.6 billion in R &D and Johnson & Johnson”
  4. 0:12:10Leading through lawsuits with the credo

    Duato explains how J&J's principles guide its response to talc litigation and the vaccine setback.

    “when the facts, the science, and the law are on our side, we stand by our products.”
  5. 0:19:20Yellen's soft-landing optimism

    Yellen describes falling inflation with a strong job market after a near government shutdown.

    “inflation is coming down in the context of an extremely strong labor market”
  6. 0:22:23Is the deficit sustainable?

    Yellen argues the right test of debt is interest costs relative to the economy, not the headline deficit.

    “service the debt, real net interest payments as a share of GDP”
  7. 0:25:05The puzzle of rising interest rates

    Yellen concedes uncertainty over whether higher long-term yields are temporary or a return to older norms.

    “a pretty significant increase in not only 10-year nominal yields, but also real yields”
  8. 0:28:21Productivity bets and AI

    Yellen ties hopes for stronger productivity to infrastructure, chips and clean-energy legislation, with caution about AI forecasts.

    “I think there will be a payoff, but I don't want to exaggerate.”
  9. 0:30:28Between FOMO and FOGI

    Murray closes with a framing of how CEOs feel about generative AI.

    “caught somewhere between FOMO, fear of missing out, and FOGI, fear of getting in.”

Transcript

0:00:04
Alan Murray

Leadership Next is powered by the folks at Deloitte, who, like me, are exploring the changing rules of business leadership and how CEOs are navigating this change. Welcome to Leadership Next, the podcast about the changing rules of business leadership. I'm Alan Murray.

0:00:24
Michal Lev-Ram

And I'm Michal Evram. Alan, I see you're back in New York after a whirlwind few days in DC. There was so much going on there, including our very own Fortune CEOI conference. I wasn't able to attend and I always have major FOMO when I miss any of our live events, but I want to know, how was it?

0:00:49
Alan Murray

What were the highlights? It was really, really good. So for listeners who don't know, the Fortune CEO initiative was created seven years ago to give CEOs of purpose-driven companies that really want to focus on improving their positive social impact on society, give them a forum where they could exchange ideas and best practices. We had about 100 CEOs in the room and a killer program. You know, we're going to do a couple of those interviews here in a moment.

0:01:20

But the thing I want to tell you is, I mean, we were talking about climate programs. We were talking about the political backlash against diversity, equity, and inclusion. We had the Secretary of Commerce and the Secretary of Treasury talking about the new industrial policy. But we kept coming back again and again to your favorite topic, which is generative AI. It's clearly so obsessing the minds of business leaders right now, it was actually almost hard to get away from it.

0:01:53
Michal Lev-Ram

Okay. Well, you did cover a lot of ground though, and I know AI is super top of mind, but one of the interviews that we're really interested in sharing with all of you was an interview that our editor-in-chief, Alyson Shontell, did with Johnson & Johnson CEO, Joaquin Duato. Tell us a little bit about that one.

0:02:14
Alan Murray

Well, it was a great interview. Alison did a really nice job. I mean, the thing about Johnson & Johnson is it has been a purpose-driven company for many years. It has this famous credo that they really train everyone at the company in. And Joaquin was a perfect representative of that credo. I think you'll get that in this conversation.

0:02:36
Michal Lev-Ram

And just for some background, Joaquin became CEO of J &J in early 2022, but he joined the company 34 years ago as part of Janssen Pharmaceuticals in his native Spain. He took over the company during a pretty rocky time for J &J when the U.S. government had phased out the company's COVID-19 vaccine. That hurt its pharmaceutical division. There are some other hurdles as well, including, you know, we all know about this settlement, $9 billion class action lawsuit alleging that J &J's baby powder had caused cancer.

0:03:11

So lots of hurdles there. And I'm curious, after listening to his conversation with Allison, do you think Duato is up to the task?

0:03:20
Alan Murray

I thought he was impressive. I mean, Allison definitely asked him about the challenges that you talked about and how he led in the face of this kind of tumult. And he was very straight and very clear. And again, hearkened back to the Johnson & Johnson credo and its purpose. And then went on to say that he thinks the company is actually about to enter its golden era.

0:03:44
Michal Lev-Ram

Well, here it is, the first of two interviews we're going to bring out from CEOI Johnson and Johnson's Joaquin Duato in conversation with Fortune Editor-in-Chief Alyson Shontell. And later on, we're going to also hear from Janet Yellen, which, Alan, I hear you have a special relationship with.

0:04:01
Alan Murray

More on that later. Let's listen to Joaquin Duato.

0:04:07
Michal Lev-Ram

Well, Joaquin, thank you so much for being here with us today.

0:04:09
Joaquin Duato

Thank you, Alison.

0:04:10
Michal Lev-Ram

So you've been in, so first I should note, Johnson & Johnson has been one of 49 companies to be in the Fortune 500 list every single year since we've made it since 1955. This year they clocked in at number 40. As Alan said, the healthcare and pharma markets have been booming. And you've been in the job for two years, but you've been at the company for 34, so you've seen quite a bit. Two years in, what's your primary focus and biggest surprise since becoming CEO?

0:04:39
Joaquin Duato

Thank you. And I'm proud to be the CEO of Johnson & Johnson. In our 130 years of history, we have had only eight CEOs. And I am the first one who is not born in the U.S., so I'm proud to represent that. And certainly, it's a great legacy that we have had during this period. So in becoming CEO of Johnson & Johnson, I have a dual purpose. One is to remain a company that is true to our mission of addressing difficult to treat diseases.

0:05:14

And the other one is to be able to continue to be a company which is principle-based, people-based, and maintains the reputation that we have had during such a long period of time.

0:05:24
Michal Lev-Ram

Now, is it true that you didn't get the job at first? I mean, not the CEO job, but initially when you were interviewing 34 years ago, they said no.

0:05:33
Joaquin Duato

It's true. So when I finished graduate school, I interviewed with Johnson & Johnson, and I didn't make it to the second interview. So then I joined another company, a pharmaceutical company, and eventually found my way back to Johnson & Johnson, and I've been here for 34 years.

0:05:50
Michal Lev-Ram

I mean, the longevity of your career there, I think, is telling, and the attrition rate is shockingly low at Johnson & Johnson, right?

0:05:57
Joaquin Duato

Yeah, it's very low. It's lower than the industry and our PR companies. And I think there's a number of reasons for having low attrition. One is the size of the company that enables people to work in different sectors and have careers within Johnson & Johnson. Sometimes I say Johnson & Johnson has its internal job market. The other one is that people simply like to work for Johnson & Johnson. our engagement levels are high people like to work for a company with a purpose in health care we are a company that pays a lot of attention to inclusion so everybody feels good when they come to work and certainly we like to believe that we are a caring company that we

0:06:41

care not only for the patients but we also care for each other so we we try to have a strong health and wellness offering for our employees so overall people like working in johnson and johnson and stay longer in johnson and Johnson. Our average tenure, for example, in the U.S. is more than a decade. So people can do careers, and we are happy of that. We are glad that people like to stay at Johnson and Johnson

0:07:03
Michal Lev-Ram

longer. So when you became CEO, and even in your memo to become CEO, you'd said, I think we should spin out the consumer business. Johnson and Johnson can compete with L 'Oreal there, but should it? And so could you speak a little bit about Kenview, which is the company that you spun out just earlier this year. It's now publicly traded. Why you did that? Why is return to focus important for Johnson versus diversification of businesses? Yeah.

0:07:32

So Canview is our consumer company.

0:07:34
Joaquin Duato

So when you think about the Johnson & Johnson and the brands that you know about Johnson & Johnson, Band-Aids, Tylenol, or baby shampoo, now they are all in Canview. Why did we decide to to separate Cambio and create a global consumer champion with Cambio because we thought that focusing on the consumer market and focusing on healthcare was going to deliver better results for consumers and for patients. For us, it was very complex to be able to compete with L 'Oreal, as you mentioned, in skincare and at the same time competing biologics with biopharmaceutical companies and in surgical robotics with medical technology companies.

0:08:15

So we thought there was a benefit for Johnson & Johnson to be exclusively focused on healthcare, on research and development, on innovation. And that was going to create a better platform for us to be true to our mission, not only in the next two or three years or post-IPO, but during a long period of time.

0:08:37
Michal Lev-Ram

One thing I do want to make sure I hit on is R &D is a huge part of Johnson & Johnson. What are you seeing in this space? You've said that this is the golden era for your business, that there will be more change and more positive movements towards curing disease over the next few years than you've seen in the last number of decades. So what are you seeing that's exciting? What are the innovations? And what are you doing with things like robotics, AI?

0:09:03

How is that all changing the industry?

0:09:04
Joaquin Duato

Yeah, so R &D is the heart of an innovation-based company. Last year, we invested $14.6 billion in R &D and Johnson & Johnson. So we are one of the largest, if not the largest, investor in R &D in life sciences. What we see now, it's a combination of more knowledge on the biology and genetics of disease with an acceleration of that due to technology. Things like artificial intelligence, machine learning, and now generative AI, it's helping us accelerate drug discovery.

0:09:42

and it's helping us also making medical technologies smarter. In the surgical side, surgeons are now able to utilize robotic-assisted techniques, better visualization, better sensors. Those instruments are connected. They can provide them insights, and they can significantly improve the average outcome of surgery. So those are things that are going to help accelerate in discovery and progress in healthcare care in a way that we have not seen in the last century.

0:10:14
Michal Lev-Ram

And one thing, we had a lunch previously, and you had mentioned, imagine knee surgery, but being done by maybe a robot versus a surgeon. I mean, think about the precision needed. I might prefer a robot for something like that than someone with a potentially shaky hand.

0:10:28
Joaquin Duato

Absolutely. All our instruments now have some component of intelligence or connectivity. So our instruments now have sensors that can measure pressure, temperature, have visualization capabilities, which at the end of the day is software, is digital, that give an idea of the surgeon of where are they in, are they going to interfere with a critical structure, and all that can be visualized. And we can even provide guidance to the surgeon real time or where they have to go.

0:11:01

So that's going to be transformational in the way we do surgery, and it's going to help improving the outcomes of a procedure, which is very common. I'm sure in the audience, every one of you have had some type of surgery during your life. So that's important if we can improve the outcomes and the quality of surgery. When I think about what we can do as a company, we have the range of technologies to be able to do what no other company can do.

0:11:26

We can do cell therapy, but we can do robotic surgery. We can do genetic or mRNA therapeutics, and we can do also smart implants. So there's a lot of things that we can do as a company based on the number of technologies and capabilities that we have.

0:11:43
Michal Lev-Ram

So as the leader of a company, you have to lead in good times and in bad. And with a company as large as Johnson & Johnson, there are hard things, and there are lawsuits. You've had talcum powder lawsuits, opioid crisis to deal with, COVID, having your vaccine essentially be dismantled. How do you lead in those hard times? How do you encourage your team to not lose morale, to stay focused on the mission when there's a lot of hardship around?

0:12:10
Joaquin Duato

Yeah, we do it with conviction. Conviction on the principles of our credo. By the way, this year is the 80th anniversary of the credo that was written. And we do it by having a trajectory of more than 100 years in which we have always tried to do the right thing for the patient. When we make a mistake, we take responsibility. And when the facts, the science, and the law are on our side, we stand by our products.

0:12:41

And we have been able to manage this balance during many years. But the people in the company working at Johnson & Johnson have a genuine passion of doing the right thing. And we don't do it for the recognition. We do it because we have convictions. And those convictions normally help an organization to manage change. I'm convinced that purpose-driven organizations are much better in managing change. And our organization has a strong tradition of being a purpose-driven one.

0:13:10

Internally, we say we are the original mission-driven company, based on the fact that our credo was written 80 years ago. 80 years ago, talking about putting the patient first, the employees, the communities, And then if you do the right thing, it's going to be good for the shareholder. It wasn't very innovative, very different. So I think that that's part of the energy that people at Johnson & Johnson have in order to navigate the ups and downs that anything in life, it's going to present you with.

0:13:39
Michal Lev-Ram

That was a really interesting conversation. I think Joaquin put in such plain language everything that we explore here on Leadership Next when he said purpose-driven companies are better equipped to manage change. And Alan, I'm wondering if you have thoughts about that.

0:13:54
Alan Murray

Well, obviously, I agree with that. But I think the other thing that I thought he captured very well was just the sense. And there were other leaders in other industries who conveyed the same sense at the conference that we are on the cusp of something very big here in terms of technological transformation. It will mean a lot to companies like his in the health care business.

0:14:15
Michal Lev-Ram

Yeah, and I think it's obviously always been a very competitive landscape in J &J's space, but it was interesting to me that he also talked about some consumer giants like L 'Oreal as a competitor today. And by the way, little teaser here, we have the CEO of L 'Oreal on an upcoming episode.

0:14:35
Alan Murray

Looking forward to that one. I'm sorry I had to miss that interview, Mahal.

0:14:39
Michal Lev-Ram

Well, you get to have FOMO too, Alan, once in a while.

0:14:42
Alan Murray

I do. Jason Garzadas, the CEO of Deloitte U.S., is the sponsor of this podcast and joins me today. Welcome, Jason. Thank you, Alan. It's great to be here. Jason, our ideas about work, where we work, when we work, how we work, all of those have continued to evolve since the pandemic. Is that a problem for business or is it an opportunity for business?

0:15:09
Jason Garzadas

That's a massive opportunity, although I think that the answer is less clear. It is a profound set of challenges, to be sure. But in the end, it's an opportunity to create a workplace, particularly in the face of more long-term, systemic talent workforce constraints and limitations that brings out the best of a workforce. So people can be their genuine self at work, can have heightened levels of productivity, and feel supported in all that they do. But I don't think the models are clear and we're seeing lots of experimentation, whether that's around hybrid and what does it mean to actually co-locate and what degree of co-location matters.

0:15:45

It's also a function of how does technology get embedded into the workplace such that employees and workforces feel supported and enabled. And also the cultural elements related to diversity, equity, inclusion and feeling supported to be your genuine self at work. It's the combination, Alan, of all those factors that leading companies will innovate around and find novel ways to bring together that will be highly desirous of leading talent and will be a differentiator in terms of businesses using their workplace and their work processes to win in new and different ways.

0:16:17
Alan Murray

Jason, thanks for your perspective and thanks for sponsoring Leadership Next.

0:16:22
Jason Garzadas

Thank you.

0:16:30
Michal Lev-Ram

So, Alan, the next conversation we're sharing with our listeners is with someone who, to you, is not just the Secretary of the Treasury or the former Chair of the Federal Reserve. So tell us, how do you know Janet Yellen?

0:16:44
Alan Murray

Well, it was a long time ago, and I'm not going to say how long it was because that'll say something about both my age and her age. But I got a master's degree in economics at the London School of Economics, and it happened to be the same year she had just gotten married and she and her new husband, George Akerlof, team taught my macroeconomics course. So for six months, I would go in every day and get what I'm sure was a brilliant but completely incomprehensible lecture from George Akerlof.

0:17:19

And then in the afternoon, Janet Yellen would come in and tidy it all up. And I said to the secretary of the treasury that what little I know about macroeconomics, I know from her.

0:17:31
Michal Lev-Ram

Not from her husband.

0:17:33
Alan Murray

Not from her husband. He's brilliant. Everyone tells me he's brilliant. So I'm sure he must be.

0:17:38
Michal Lev-Ram

And hopefully you got a good grade.

0:17:40
Alan Murray

I did. I did. I did very well. And she said that it was an honor to have me as a student, which I suspect she says to all her students, but I'm going to take it as a personal accolade.

0:17:54
Michal Lev-Ram

But this was very exciting. She joined you on stage actually just a few days after the government narrowly avoided shutting down. It was a thrilling few days for all of us. And overall, it's just a really complicated time for the U.S. and for the U.S. economy for a number of reasons. You know, as we're seeing this unfold, it's gotten even more complex. So as a whole, did you walk away thinking she was optimistic about the state of the economy?

0:18:23
Alan Murray

Two things. One is I think she's optimistic. and two is she's still the same person who stood at the front of that classroom so many years ago and can take very complicated subjects and make them sound very simple and clear. So it's worth listening to. Here she is, Secretary of the Treasury Janet Yellen. It's so good to see you.

0:18:48
Janet Yellen

Pleasure to see you, Ellen.

0:18:49
Alan Murray

Really, really appreciate you being here. So we had a wild weekend. You had a wild weekend.

0:18:56
Janet Yellen

We're all waiting to see whether the government would stay open or shut down.

0:19:02
Alan Murray

And really all that happened was they kicked the ball down the road 45 days. And Moody's is threatening to downgrade U.S. debt. So I guess the first question for you is, is this mess going to change the relative optimism you had about the U.S. economic outlook?

0:19:20
Janet Yellen

Look, I'm very optimistic about the U.S. economic outlook. Short term, inflation is coming down in the context of an extremely strong labor market, what people would normally call a soft landing.

0:19:39
Alan Murray

Which is amazing, by the way. It hardly ever happens.

0:19:41
Janet Yellen

Correct. And it's great because, of course, we want to see inflation come down. It's been burdening Americans, but we want to maintain the good, strong labor market that we have. And we seem to be on that kind of path. And medium term, we're now engaging in a very substantial program of investments to strengthen our economy, to boost our productive capacity, to boost productivity growth, to draw more American workers into the labor market, and to address longstanding structural problems like climate change and inequality across people, races, and places.

0:20:30
Alan Murray

I want to talk about that. But before I do, I suppose I should let this group in on a little secret about our past. Yeah, which I hesitate to do because it highlights my age and may then also highlight your age. May well do. But I have a master's degree in economics, which I got at the London School of Economics, which was the one year that Secretary Yellen taught there. So she taught what little I know about macroeconomics.

0:21:01

I learned from Janet Yellen. It was an honor to have you as my student. I have wonderful memories of you drawing ISLM curves and Phillips curves on that big blackboard.

0:21:12
Janet Yellen

Great tools.

0:21:14
Alan Murray

So I ask this question with that in mind. The people who almost hung us up this weekend are concerned about government spending. We have a budget deficit of $1.5 1 trillion. If I had said to you back when we were at the London School of Economics that we were going to end up in that place, I think you would have used your courage to show me that's not a good scenario. So how is it that that's okay?

0:21:41

Okay, that's a great question. And as Treasury Secretary,

0:21:45
Janet Yellen

I feel it's my job to worry about fiscal sustainability. So I do think it's critical that we establish spending and revenue targets that put us on a path where fiscal policy is sustainable, and a path that's consistent with solid growth. And I believe at the moment we're on such a path. So one way to judge it, because our economy is now all about big numbers and 1 trillion is certainly a big number. 1 trillion and a half.

0:22:23

Our economy has a large GDP and so forth. I think the metric that I think is most relevant to judging fiscal sustainability is the amount that we're spending to service the debt, real net interest payments as a share of GDP. How much of our GDP goes to service the debt? And the answer over the next 10 years in the mid-session review, which is the most recent budget forecasts that the administration prepared, the answer is 1%.

0:23:03

So real net interest as a share of GDP is about 1%. That's historically completely normal. normal. Some guidelines would say try to keep it under 2%, but it's 1 % for the next decade. Now, I will say that that budget does assume meaningful deficit reduction over the next 10 years. There were $3 1 trillion of deficit reduction incorporated into it, along with a significant program of investments in our economy, but ones that are financed by collecting greater revenues in a way that we think is fair, where the burden largely falls on corporations and very high income

0:23:53
Alan Murray

taxpayers. And I do want to come back to the investment piece of it. But before I do, I mean, the other thing that that assumption depends on is how high, how long do interest rates... stay, which is a big issue, not just for the government, but for any company that's carrying a substantial amount of debt. How long are we going to, you know, are we going to have to roll over all our debt at rates that are double what we initially had?

0:24:20

So tell them the answer.

0:24:22
Janet Yellen

The answer is, I don't know. And it's a great question. And it's one that's very much on my and the administration's minds. When the administration came in, it was the pandemic. We had had a decade of interest rates. Short-term interest rates were zero, long-term interest rates higher, but very much lower than today's interest rates. And the interest burden was almost non-existent at that point. Now, the forecast we've made, assume that interest rates will rise toward more normal levels.

0:25:05

But we are seeing, especially over the last several months, a pretty significant increase in not only 10-year nominal yields, but also real yields. And there's a question mark just why that is.

0:25:22
Alan Murray

Are we going back to something that looks more like the history prior to 10 years ago than the

0:25:28
Janet Yellen

last 10 years. That's right. And that's a very important question. One view is that it may take a longer period of somewhat higher interest rates to control inflation to keep it down, but medium-term interest rates will go back to more normal levels. It's also possible that longer-term interest rates will be higher than we thought. But I would point out that for many decades, the level of real interest rates, not only in the United States, but in many advanced economies, had been moving down.

0:26:05

And it was felt by most economists that there were strong structural reasons why that was occurring. This is why I loved you as a teacher way back when,

0:26:16
Alan Murray

because you could explain to me both sides of the equation. The other thing we've been talking about here today is the extraordinarily quick adoption of generative AI technology. I think Eric Brynolfsson said earlier that most waves of technology take like 10 years before you start to see them in the productivity numbers. He thinks this one's going to be much faster. We've seen, we've heard lots of anecdotal evidence of huge productivity gains. If I studied my books correctly way back then, big increases in productivity could make a huge difference to all the things we're talking about, growth, inflation, et cetera.

0:26:57

We've had disappointing productivity for the last decade. Are we on the verge of something significantly better?

0:27:02
Janet Yellen

So I will say I'm not an expert in AI. From what I understand, as you just said, the progress in this area is unbelievably rapid, and I think it could make a significant difference. As an administration, as a country, we're also working on a whole set of investments that should be productivity boosting over the medium term. We're addressing the problem of crumbling roads and highways and infrastructure that really hasn't been appropriately designed for a modern economy.

0:27:47

We have a huge, you know, we passed really a trifecta of legislation, the bipartisan infrastructure bill, the Chips and Semiconductor Act, and then the Inflation Reduction Act. So we're investing in R &D in ways we haven't in decades, restoring U.S. leadership in science and technology. We have a huge program of incentives for clean energy investment.

0:28:18
Alan Murray

So you're betting on a significant increase in productivity.

0:28:21
Janet Yellen

Yes, but let me be careful because productivity growth, usually a tenth or two here or there, is regarded as a big thing. So I don't want to pull numbers out of a hat that are gigantic.!! I think there will be a payoff, but I don't want to exaggerate.

0:28:41
Michal Lev-Ram

Alan, Secretary Yellen does sound optimistic, but I'm curious, what about you? How are you feeling about the current state of the economy? Not just after your conversation with her, but after CEOI in general and after spending a few days in our nation's capital?

0:28:57
Alan Murray

Oh, Mahal, it's a complicated question. It was certainly mixed. I mean, it is pretty remarkable, given that every CEO we talked to six months ago was predicting a recession, that we are where we are, not in a recession. It looks like the fabled soft landing may actually happen. And that's what she thinks. And I agree with her. But that doesn't mean there aren't some storm clouds on the horizon. Certainly, the fact that interest rates are as high as they are and seem to be staying there.

0:29:28

And so anybody with lots of debt is going to be saddled with extra costs. And we're probably going to see bankruptcies and other problems. And she talked about that some as well. But on the good side, going back to AI.

0:29:42
Michal Lev-Ram

With bankruptcies and other problems? Yeah, this sounds great.

0:29:46
Alan Murray

And war too. We got into geopolitics. But on the good side, and this goes back to AI, the potential for big improvements in productivity and the macroeconomic effects that has helping to bring down inflation and increase growth was on everybody's mind.

0:30:05
Michal Lev-Ram

Yeah, it was really interesting. I got to watch snippets from afar and follow the coverage. And like you said at the top, I mean, AI was kind of this thread throughout and definitely a silver lining. I know obviously there's a lot to be worked out there and a lot of risks and concerns, but also tons of opportunities, which we heard from both the DC types and the business types.

0:30:28
Alan Murray

Jennifer Tejada, who you know, who's the CEO of PagerDuty and was our co-chair for the conference, led a town hall discussion on the AI topic. And she said, and I thought this captured it perfectly, that most of the big company CEOs seem to be caught somewhere between FOMO, fear of missing out, and FOGI, fear of getting in. I thought that was a perfect way of capturing the moment.

0:30:55
Michal Lev-Ram

Well, we all need new acronyms in our lives. So thank you, Jennifer, for that. We definitely want to keep our listeners up to date as the way leaders lead continues to evolve and as the world does. And of course, as AI enters the fray more and more.

0:31:10
Alan Murray

We certainly will, Mahal. And we'll see you next week on a new episode of Leadership Next. Leadership Next is edited and produced by Alexis Hott. Our theme is by Jason Snell. Our executive producer is Megan Arnold. Leadership Next is a product of Fortune Media. featured on the episodes.